Study findings challenge the content validity of the Canadian Consensus Criteria for adolescent chronic fatigue syndrome.
Asprusten, Tarjei Tørre, Fagermoen, Even, Sulheim, Dag et al. · Acta paediatrica (Oslo, Norway : 1992) · 2015 · DOI
Quick Summary
Researchers tested whether the Canadian Consensus Criteria—a set of guidelines used to diagnose ME/CFS in teenagers—actually identify meaningful differences between patients. They compared 120 adolescents with ME/CFS, grouping them by whether they met these criteria or not. The study found that the two groups were nearly identical in most disease markers and how they recovered over time, suggesting the criteria may not be capturing important real-world differences between patients.
Why It Matters
This study questions whether the Canadian Consensus Criteria—widely used diagnostic guidelines for adolescent ME/CFS—actually distinguish clinically meaningful subgroups. If the criteria don't identify real biological or prognostic differences, researchers and clinicians may need better diagnostic tools to identify which patients will recover and which may develop chronic illness.
Observed Findings
46 patients met Canadian Consensus Criteria; 69 did not; 5 were unclassifiable.
Criteria-positive patients showed poorer performance on digit span backward (cognitive test) compared to Criteria-negative patients.
All other disease markers showed no significant differences between the two groups.
Prognostic outcomes over 30 weeks were equivalent between Criteria-positive and Criteria-negative groups.
Inferred Conclusions
The Canadian Consensus Criteria may lack content validity for adolescent ME/CFS because they do not distinguish between patients with different disease markers or prognoses.
Cognitive deficits were the only notable difference, suggesting the criteria may not be capturing the biological complexity of the disease.
The criteria require re-evaluation or refinement for better clinical utility in adolescent populations.
Remaining Questions
What disease characteristics or biomarkers would better distinguish clinically meaningful subgroups within adolescent ME/CFS?
Do the criteria perform differently in adult ME/CFS populations?
Why did digit span backward performance differ while other cognitive measures did not?
What This Study Does Not Prove
This study does not prove the Canadian Consensus Criteria are clinically useless, only that they may lack content validity in this adolescent population. It does not establish what the criteria should measure or identify the optimal diagnostic approach for ME/CFS. The findings may not generalize to adult populations or patients selected under stricter inclusion criteria.